Read More Healthcare Industry News Stem cell-based diabetes therapies at ADA 2025 show promise in eliminating insulin use for type 1 patients VX-880 and immune-shielded stem cell islets show strong promise in clinical trials at ADA 2025, offering new possibilities in type 1 diabetes treatment. byPallavi MadhirajuJune 22, 2025